Work is set to get underway on a “game-changing” project which will see people with type 2 diabetes (T2DM) offered new digital learning and self-management support to help them manage their condition.

The project, called GM Diabetes MyWay (GMDMW), has been awarded almost £1m by NHS England and the Department of Health and Social Care.

The Greater Manchester Health and Social Care Partnership (GMHSC Partnership), the body made up of NHS organisations, councils and others with responsibility for the city region’s devolved £6 billion health and care budget, will now work with the project’s partners to rollout the programme, which aims to support the estimated 150,000 people in the city region who have T2DM.

A new online platform for GM will allow people with T2DM to access education and learning materials, upload glucose monitoring data and view their own care record. Other digital innovations will also be tested, which will offer:

• Support for people with mental and emotional difficulties
• Virtual video consultations with clinicians
• On-line coaching to lead more active and healthy lives
• Incentives to improve attendance at clinics

Jon Rouse, Chief Officer at the GMHSC Partnership, said: “We are delighted with this announcement and proud such confidence has been shown in the Greater Manchester team and its partners to deliver this groundbreaking project. It has the potential to improve the lives of thousands of people.

“Devolution has given Greater Manchester an exciting opportunity to rethink how it delivers health and social care to its citizens and this will be a great project to develop in this new environment.”

The funding has come from NHS England’s Test Beds programme, which trials combinations of digital technologies with pathway redesign in a clinical setting with real patients. The programme is run in conjunction with Innovate UK.

Naresh Kanumilli, a Manchester GP who helped to design the project with the GMHSC Partnership, said: “This has the potential to have a real impact in Greater Manchester. With a large and growing population living with T2DM, we need to harness the power of new digital technology to embrace changes in how we support people living with diabetes.”

There is currently little access to education other than in traditional classroom-based formats for people with diabetes, which can be difficult for many to access to improve the way they manage the condition. The GMDMW project will provide much more flexible access for a wider range of people to a wider range of support.

It is expected the digital support will become available for people in Greater Manchester next year.

- ends -


Notes to editors:

For media enquiries, contact the GMHSC Partnership’s press office on 0161 625 7463 or gm.hsccomms@nhs.net, or Ewan Jones, Programme Manager, on 0113 825 5227 or ewanjones@nhs.net.

The GM Diabetes MyWay (GDMW) project is a collaborative led by the Greater Manchester and Eastern Cheshire Strategic Clinical Networks (SCNs) which will provide people with diabetes with a new one-stop digital platform designed to help them self-manage their condition more effectively and provide education on how to do this. The SCNs are led by the GMHSC Partnership.

It is one of seven Test Beds from Wave 2 of the NHS England’s Test Bed funding programme and has received a grant of £975,000 towards the £1.2m project cost, with the remainder contributed by the industry partners involved.

GMDMW will give people living with T2DM:
• 250+ digital educational resources (text, video, interactive content).
• Diabetes self-management support with tailored advice based on personal needs.
• Access to personal diabetes medical and care records.
• Personalised care planning, goal-setting tools and service directories.
• Glucose monitoring displays allowing the upload and sharing of blood sugar data with clinicians.

The project partners collaborating in GM are:
• Greater Manchester and Eastern Cheshire Strategic Clinical Networks – NHS lead organisation providing project management and clinical guidance.
• MyWay Digital Health Limited - the award-winning MyDiabetesMyWay platform will enable health record/data-driven education access for people with diabetes, and act as an integrator platform for other services.
• Billaway Health Limited - helps engagement with patients. As people engage, they automatically earn credit to monthly bills like mobile phone, utility, financial services, insurance and social media & entertainment.
• Changing Health Limited - provides behaviour change programmes for people with Type 2 diabetes, pre-diabetes, and weight management, clinically proven to transform health outcomes.
• MyCognition Limited - MyCognition’s App will assess and enhance people’s cognitive health, helping them better manage their T2DM and protecting mental well-being.
• Oviva Limited - a new type of healthcare provider using virtual clinics and high-frequency follow-ups to increase system capacity, improve clinical outcomes and lower the cost of delivering care.
• The Smart Care Doc Company Limited - providing secure online virtual consultations between NHS clinicians and their own patients
• The University of Manchester - The University of Manchester, part of the prestigious groups of universities, is a truly global institution, with a reputation for education and innovation that resonates across the world.

 

NHS England

NHS England leads the National Health Service (NHS) in England. It sets the priorities and direction of the NHS and encourages and informs the national debate to improve health and care.
It wants everyone to have greater control of their health and their wellbeing, and to be supported to live longer, healthier lives by high quality health and care services that are compassionate, inclusive and constantly-improving.
NHS England shares out more than £100 billion in funds and holds organisations to account for spending this money effectively for patients and efficiently for the tax payer.
For further information, visit https://www.england.nhs.uk/about/about-nhs-england/

 

Innovate UK

Innovate UK is the UK’s innovation agency. It is part of UK Research and Innovation, a non-departmental public body funded by a grant-in-aid from the UK government and drives productivity and economic growth by supporting businesses to develop and realise the potential of new ideas.

It connects businesses to the partners, customers and investors that can help them turn ideas into commercially successful products and services and business growth.

Its support is available to businesses across all economic sectors, value chains and UK regions. For more information, visit www.innovateuk.ukri.org